Together Pharma Ltd
TGPHF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 10.8% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38% | 38% | 38.5% | 38.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.2% | 30.2% | 27.2% | 27.2% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 12.6% | 12.6% | -19.6% | -19.6% |
| EPS Diluted | 0.25 | 0.25 | -0.51 | -0.51 |
| % Growth | 0% | 149% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |